Characteristics Associated With Bone Mineral Density Screening in Adults With Intellectual Disabilities

Article Figures & Data

Table 1. Bivariate Analysis: Men

Variable	People (n)	People Who Were Screened (%)	Crude OR	95% CI
Individual characteristics
Age (years)
19–24	293	5.1	0.13	0.06–0.03
25–34	544	9.2	0.24	0.13–0.44
35–44	775	10.8	0.29	0.17–0.52
45–54	757	14.1	0.40	0.23–0.69
55–64	407	20.6	0.62	0.35–1.1
65–74	162	25.3	0.81	0.43–1.5
≥75	68	29.4	Reference
Antiepileptic medications
Yes	919	18.9	1.9	1.5–2.4
No	2087	10.9	Reference
Proton pump inhibitor
Yes	521	20.2	1.9	1.5–2.4
No	2485	11.9	Reference
Vitamin D
Yes	202	43.1	6.0	4.4–8.1
No	2804	11.2	Reference
Special positioning
Yes	119	27.7	2.6	1.7–3.9
No	2679	13.0	Reference
Ambulation
Any assistance needed	776	24.7	3.2	2.6–3.9
Independent	2194	9.4	Reference
History of fracture
Yes	346	28.9	3.2	2.5–4.1
No	2660	11.3	Reference
Cooperates with exams
Uncooperative	1318	15.2	1.3	1.1–1.6
Cooperative	1688	11.9	Reference
Thyroid abnormalities
Yes	365	17.0	1.4	1.0–1.9
No	2641	12.8	Reference
Down syndrome
Yes	368	8.7	0.58	0.40–0.86
No	2638	14.0	Reference
Diet texture
Unusual	648	22.7	2.4	1.9–3.0
Normal	2324	10.8	Reference
Interpersonal characteristics
Guardian
Yes	2026	14.7	1.5	1.2–1.9
No	980	10.5	Reference
Received a flu shot during the time period studied
Yes	1850	16.7	2.3	1.8–2.9
No	1156	8.0	Reference
Organizational characteristics
Residential setting
24-hour support	1952	15.7	1.9	1.5–2.2
<24-hour support	1054	8.9	Reference
Nursing-supported care coordination
Yes	1175	14.6	1.2	0.96–1.5
No	1710	12.5	Reference

Table 2. Bivariate Analysis: Women

Variable	People (n)	People Who Were Screened (%)	Crude OR	95% CI
Individual characteristics
Age (years)
19–24	228	11.0	0.048	0.022–0.11
25–34	513	11.9	0.054	0.026–0.11
35–44	624	22.3	0.11	0.056–0.22
45–54	657	44.9	0.32	0.16–0.63
55–64	337	67.3	0.81	0.40–1.6
65–74	110	79.8	1.5	0.69–3.5
≥75	43	72.1	Reference
Antiepileptic medications
Yes	696	41.8	1.6	1.3–1.9
No	1811	31.5	Reference
Proton Pump Inhibitor
Yes	388	44.9	1.7	1.4–2.1
No	2119	32.5	Reference
Vitamin D
Yes	406	63.3	4.3	3.4–5.3
No	2101	28.8	Reference
Depo-Provera use
Yes	132	40.2	1.3	0.91–1.9
No	2375	34.1	Reference
Menstruation
Yes	1527	19.9	0.18	0.15–0.22
No	810	57.7	Reference
Special positioning
Yes	110	40.0	1.3	0.86–1.9
No	2211	34.3	Reference
Ambulation
Any assistance needed	801	46.3	2.1	1.8–2.5
Independent	1665	28.8	Reference
History of fracture
Yes	313	47.9	1.9	1.5–2.4
No	2194	32.5	Reference
Cooperates with exams
Uncooperative	1055	35.0	1.0	0.89–1.2
Cooperative	1452	34.0	Reference
Thyroid abnormalities
Yes	539	43.4	1.6	1.3–2.0
No	1968	31.9	Reference
Down syndrome
Yes	295	28.1	0.72	0.55–0.94
No	2212	35.2	Reference
Diet texture
Unusual	546	46.7	2.0	1.6–2.4
Normal	1930	30.9	Reference
Interpersonal characteristics
Guardian
Yes	1563	35.7	1.2	0.98–1.4
No	944	32.2	Reference
Received a flu shot during the time period studied
Yes	1621	40.4	2.2	1.8–2.7
No	886	23.4	Reference
Organizational characteristics
Residential setting
24-hour support	1570	39.2	1.8	1.5–2.2
<24-hr support	937	26.3	Reference
Nursing-supported care coordination
Yes	930	36.3	1.2	0.98–1.4
No	1497	32.9	Reference

Table 3. Logistic Regression: Female Model

Variable	Crude OR	Adjusted OR	95% CI
Individual characteristics
Age (years)
19–24	0.048	0.068	0.03–0.16
25–34	0.052	0.062	0.029–0.13
35–44	0.11	0.12	0.06–0.25
45–54	0.32	0.36	0.18–0.75
55–64	0.80	0.93	0.45–1.9
65–74	1.5	1.6	0.69–3.7
≥75 (Reference)	1.0	1.0	Reference
Antiepileptic medication	1.6	1.5	1.2–1.9
Proton pump inhibitor	1.7	1.3	1.0–1.7
Vitamin D	4.3	3.4	2.6–4.4
Depo-Provera use	1.3	1.8	1.2–2.7
Down syndrome	0.72	0.72	0.52–0.98
Needs assistance with ambulation	2.1	1.3	1.0–1.6
History of fracture	1.9	1.3	1.0–1.8
Cooperative with exams	1.0	0.70	0.56–0.87
Interpersonal characteristic
Received a flu shot during the time period studied	2.2	1.4	1.1–1.8
Organizational characteristic
24-hour supported residential setting	1.8	1.3	1.1–1.7